SCIENTURE HOLDINGS, INC. Increase (Decrease) in Other Current Assets
SCIENTURE HOLDINGS, INC. (SCNX) reported Increase (Decrease) in Other Current Assets of $89.34 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2021-03-29
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current assets for the quarter ending 2018-09-30 was $20.96K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current assets for the quarter ending 2017-09-30 was -$2.31K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current assets for the quarter ending 2016-09-30 was -$5.15K, a 108.37% decline year-over-year.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current assets for the quarter ending 2016-06-30 was -$15.85K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current assets for fiscal 2019 was $89.34K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current assets for fiscal 2015 was -$123.78K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other current assets for fiscal 2014 was -$59.58K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 3 month as first filed | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $89.34K 10-K · filed 2021-03-29 | ||||
| 2018-09-30 | $20.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $20.50K 10-Q · filed 2019-10-28 | |||
| 2018-06-30 | -$462.00 10-Q · filed 2018-07-27 | ||||
| 2017-09-30 | -$2.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $2.26K 10-Q · filed 2018-10-26 | |||
| 2017-06-30 | $4.58K 10-Q · filed 2018-07-27 | ||||
| 2016-09-30 | -$5.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$21.00K derived: sum of 2 quarters · filed 2017-11-07 | -$5.15K 10-Q · filed 2017-11-07 | -$164.30K derived: sum of 4 quarters · filed 2017-11-07 | |
| 2016-06-30 | -$15.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $0.00 10-Q · filed 2017-08-04 | -$159.15K derived: sum of 3 quarters · filed 2017-08-04 | -$97.65K derived: sum of 4 quarters · filed 2017-08-04 | |
| 2016-03-31 | $15.85K 10-Q · filed 2016-04-20 | -$143.30K derived: sum of 2 quarters · filed 2016-04-20 | -$81.80K derived: sum of 3 quarters · filed 2016-04-20 | -$107.92K derived: sum of 4 quarters · filed 2016-04-20 | |
| 2015-12-31 | -$159.15K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$97.65K derived: sum of 2 quarters · filed 2016-03-28 | -$123.78K derived: sum of 3 quarters · filed 2016-03-28 | -$123.78K 10-K · filed 2016-03-28 | |
| 2015-09-30 | $61.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $35.37K derived: sum of 2 quarters · filed 2015-11-02 | $35.37K 10-Q · filed 2015-11-02 | -$24.21K derived: sum of 4 quarters · filed 2016-04-20 | |
| 2015-06-30 | -$26.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$26.12K 10-Q · filed 2015-07-30 | -$85.70K derived: sum of 3 quarters · filed 2016-04-20 | -$85.70K derived: sum of 4 quarters · filed 2016-04-20 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-04-20 | $56.93K 10-Q · filed 2015-05-04 | -$59.58K derived: sum of 2 quarters · filed 2016-04-20 | -$59.58K derived: sum of 3 quarters · filed 2016-04-20 | |
| 2014-12-31 | -$59.58K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$59.58K derived: sum of 2 quarters · filed 2016-03-28 | -$59.58K 10-K · filed 2016-03-28 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $0.00 10-Q · filed 2015-11-02 | |||
| 2014-06-30 | $0.00 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |